Tricuspid stenosis cardiac catheterization: Difference between revisions
No edit summary |
Rim Halaby (talk | contribs) No edit summary |
||
| Line 1: | Line 1: | ||
__NOTOC__ | |||
{{Tricuspid stenosis}} | {{Tricuspid stenosis}} | ||
{{CMG}} | {{CMG}} | ||
==Overview== | |||
While [[echocardiography]] remains the diagnostic imaging modality of choice, [[cardiac catheterization]] is useful to evaluate tricuspid stenosis when the results of the non-invasive testing are insufficient, particularly among patients who are being evaluated for other conditions such as [[mitral stenosis]] and [[pulmonary hypertension]]. | |||
==Cardiac Catheterization== | ==Cardiac Catheterization== | ||
Revision as of 23:10, 17 September 2014
|
Tricuspid stenosis Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Tricuspid stenosis cardiac catheterization On the Web |
|
American Roentgen Ray Society Images of Tricuspid stenosis cardiac catheterization |
|
Risk calculators and risk factors for Tricuspid stenosis cardiac catheterization |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
While echocardiography remains the diagnostic imaging modality of choice, cardiac catheterization is useful to evaluate tricuspid stenosis when the results of the non-invasive testing are insufficient, particularly among patients who are being evaluated for other conditions such as mitral stenosis and pulmonary hypertension.
Cardiac Catheterization
During diastole, there is a gradient between the right atrial (RA) and right ventricular (RV) diastolic pressure (RA is higher than RVEDP). A large a wave may be seen on the RA tracing.
- Cardiac cathertization:
- In the older pre-surgery population, this may be necessary in order to assess concomitant artery disease.
- Cathertization of the right heart:
- Used as a tool to evaluate the gradient across the valve and valve area
- Used in diagnosis of associated congenital defects
- Cathertization of the left heart:
- Useful when assessing aortic and mitral valves in patients with rheumatic disease
2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease: Executive Summary[1]
| Class IIb |
| "1. Invasive hemodynamic assessment of severity of TS may be considered in symptomatic patients when clinical and noninvasive data are discordant. (Level of Evidence: C)" |
References
- ↑ Nishimura RA, Otto CM, Bonow RO, Carabello BA, Erwin JP, Guyton RA; et al. (2014). "2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines". Circulation. doi:10.1161/CIR.0000000000000029. PMID 24589852.